Contract 36F79722D0202
Cti Biopharma Corp. · Department Of Veterans Affairs · August 26, 2022
Cti Biopharma Corp. was awarded a federal contract by Department Of Veterans Affairs on August 26, 2022 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 1, 2025. If all options are exercised, the contract could reach $3.00 million.
Contract details
- PIID
- 36F79722D0202
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 26, 2022
- Latest action
- October 1, 2025
Description
CONTRACT CANCELLATION
Modification timeline
-
October 1, 2025Mod P00009$0
-
September 19, 2025Mod P00008PRODUCT DELETION$0
-
December 19, 2024Mod P00007OGA ONLY$0
-
December 11, 2024Mod P00006PUBLIC LAW 2025$0
-
April 19, 2024Mod P00005ADMINISTRATION CHANGE (POC)$0
-
December 15, 2023Mod P000042024 PUBLIC LAW PRICING UPDATES$0
-
November 14, 2023Mod P00003ADMINISTRATION CHANGE SIGNATORY$0
-
December 13, 2022Mod P00002ADMINISTRATION CHANGE SIGNATORY$0
-
November 28, 2022Mod P000012023 PUBLIC LAW PRICING UPDATES$0
-
August 26, 2022Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79722D0202?
Contract 36F79722D0202 is a federal contract awarded to Cti Biopharma Corp. by Department Of Veterans Affairs on August 26, 2022 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 9 times since the base award.
Who won contract 36F79722D0202?
Cti Biopharma Corp. won contract 36F79722D0202 from Department Of Veterans Affairs.
How much is contract 36F79722D0202 worth?
Contract 36F79722D0202 has obligated $0 to date but carries a potential ceiling of $3.00 million if fully funded and all options are exercised.